We had the pleasure of video interviewing Vered Caplan, CEO of Orgenesis, at the latest ISCT convention in Paris (2023).

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F

Meet MAPSULES: metal iron-based nanocapsules that deliver targeted chemotherapy to solid tumors

An insight into the complexities of Alzheimer’s disease and the ongoing pursuit for breakthrough therapies

Pharma experts discuss the most exciting industry breakthroughs in recent years

K604 offer potential new treatment for ROP

Immunotherapy Viaskin Peanut shows promising results in desensitizing peanut-allergic toddlers.

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

Self-assembling “super-sized” nanocages could encapsulate and deliver drugs to specific targets in the body.